Home
Bios Clinical Opportunity Fund, Director: Actuate Therapeutics ACTU Sell · Filed 24/08/20
Trade details
- Type
- Insider sale
- Amount
- $18,592
- Shares · price
- 2,324 sh · $8.00 a share
- Held after
- 131,248 sh
- Trade date
- 24/08/14
- Filed
- 24/08/20
- Days to filing
- 6 days
Sold 1.7% of holdings
- Share of holding sold
- 1.7%
Actuate Therapeutics trades, last 26 weeks
What else happened in Actuate Therapeutics around then
Filed or reported within 30 days of the trade day · 24/07/15~24/09/13Bios Clinical Opportunity Fund's recent trades
- Bios Clinical Opportunity Fund
BuyActuate Therapeutics
BuyActuate Therapeutics
ACTU
$500K
71,428 sh
$500K
Filed 25/06/30
Traded 25/06/27
- Bios Clinical Opportunity Fund
SellActuate Therapeutics
SellActuate Therapeutics
ACTU
$138.9K
17,361 sh
$138.9K
Filed 24/08/20
Traded 24/08/14
- Bios Clinical Opportunity Fund
SellActuate Therapeutics
SellActuate Therapeutics
ACTU
$42.5K
5,314 sh
$42.5K
Filed 24/08/20
Traded 24/08/14
- Bios Clinical Opportunity Fund
BuyActuate Therapeutics
BuyActuate Therapeutics
ACTU
$3M
375,000 sh
$3M
Filed 24/08/14
Traded 24/08/14
- Bios Clinical Opportunity Fund
BuyActuate Therapeutics
BuyActuate Therapeutics
ACTU
$1M
125,000 sh
$1M
Filed 24/08/14
Traded 24/08/14